2m 2m 2m 2m 2m 2m 2m
China SXT Phrm-A (SXTC)
NASDAQ
$1.71-$0.02 (-0.98%)
Price as of Jun 03, 2026 7:56 PM EDT- N/AMarket Cap
- -99.09%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
China SXT Phrm-A (SXTC)
$1.71-$0.02 (-0.98%)
Annual
Quarterly
03/31/2025 | 03/31/2024 | 03/31/2023 | 03/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.7M -9.73% | 1.9M -2.19% | 2.0M -24.23% | 2.6M -45.53% | |
Cost of Revenue | 1.4M -0.08% | 1.4M -11.06% | 1.5M +14.42% | 1.4M -30.31% | |
Gross Profit | 367,427 -33.67% | 553,971 +29.96% | 426,271 -65.94% | 1.3M -55.92% | |
Sales and Marketing Expense | 289,859 -33.15% | 433,566 +11.90% | 387,452 -58.09% | 924,538 -41.76% | |
Research and Development Expense | N/A N/A | -184,194 N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 82,297 -59.51% | 203,247 -18.75% | 250,162 -21.83% | 320,007 -7.36% | |
Total Operating Expenses | 3.0M -0.69% | 3.1M -49.13% | 6.0M -6.33% | 6.4M +27.89% | |
Operating Profit | -2.7M +6.57% | -2.5M -55.15% | -5.6M +8.05% | -5.2M +136.21% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -19,586 N/A | N/A N/A | -476,776 +1,199.29% | -36,695 -97.73% | |
Interest Income and Expense and Net | -19,586 N/A | 0 +100.00% | -476,776 +1,199.29% | -36,695 -97.73% | |
Total Nonoperating Income and Expense | -623,173 +6.83% | -583,315 +78.24% | -327,263 +49.93% | -218,276 -70.65% | |
Income before Taxes | -3.3M +6.62% | -3.1M -47.79% | -5.9M +9.74% | -5.4M +83.89% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | 328,146 +270.30% | |
Extraordinary Items | N/A N/A | 401,995 +15.06% | 349,390 N/A | N/A N/A | |
Net Income | -3.3M +6.62% | -3.1M -47.79% | -5.9M +3.46% | -5.7M +108.72% | |
Net Income from Continuing Operations Applicable to Common | -3.3M +6.62% | -3.1M -47.79% | -5.9M +9.74% | -5.4M +83.89% | |
Basic EPS and Net Income | -2.32 -35.02% | -3.57 +301.80% | -0.89 -116.11% | 5.52 +2,788.48% | |
Diluted EPS and Net Income | -2.32 -35.02% | -3.57 +301.80% | -0.89 -116.11% | 5.52 +2,788.48% | |
Basic Weighted Average Shares | 1.4M +64.08% | 867,422 -87.00% | 6.7M +541.91% | 1.0M -92.77% | |
Diluted Weighted Average Shares | 1.4M +64.08% | 867,422 -87.00% | 6.7M +541.91% | 1.0M -92.77% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 18.1M +49.95% | 12.1M -30.50% | 17.4M +11.88% | 15.5M +16.44% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 18.1M +49.95% | 12.1M -30.50% | 17.4M +11.88% | 15.5M +16.44% | |
Total Current Assets | 21.3M +49.62% | 14.2M -27.09% | 19.5M -13.05% | 22.5M -3.36% | |
Accumulated Depreciation | 2.0M +0.21% | 2.0M +5.22% | 1.9M +5.58% | 1.8M +25.00% | |
Property and Plant and Equipment and Net | 178,561 -45.70% | 328,845 -65.82% | 962,214 -21.63% | 1.2M -14.35% | |
Total Long-Term Assets | 367,017 -95.87% | 8.9M -11.35% | 10.0M -9.57% | 11.1M -1.94% | |
Total Assets | 21.7M -6.33% | 23.1M -21.75% | 29.6M -11.90% | 33.5M -2.90% | |
Income Taxes Payable | 1.0M -2.00% | 1.1M -4.74% | 1.1M -5.38% | 1.2M +0.56% | |
Total Short-Term Debt | 710,965 +38.22% | 514,383 +193.40% | 175,316 -98.37% | 10.7M -11.67% | |
Total Current Liabilities | 6.0M -32.46% | 8.9M -38.59% | 14.5M -15.33% | 17.1M -7.85% | |
Total Long-Term Debt | 96,264 -17.81% | 117,129 -0.62% | 117,862 N/A | N/A N/A | |
Total Long-Term Liabilities | 211,683 -28.16% | 294,667 -19.45% | 365,823 N/A | N/A N/A | |
Total Liabilities | 6.2M -32.33% | 9.2M -38.12% | 14.9M -13.19% | 17.1M -7.88% | |
Retained Earnings | -28.0M +13.37% | -24.7M +14.34% | -21.6M +37.77% | -15.7M +57.64% | |
Total Stockholders Equity | 15.4M +10.83% | 13.9M -5.18% | 14.7M -10.55% | 16.4M +2.90% | |
Total Shares Outstanding | 13.8M +520.47% | 2.2M -80.60% | 11.4M +462.87% | 2.0M -86.92% | |
Cash Flow | |||||
Cash from Operating Activities | -2.3M +21.64% | -1.9M +2,287.47% | -80,757 -130.10% | 268,293 +120.38% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 63,516 +140.38% | 26,423 +314.77% | -12,303 -73.77% | -46,909 -99.19% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.4M +420.04% | -2.6M -189.22% | 2.9M +84.41% | 1.6M -87.15% | |
Financials Ratio | |||||
Gross Margin | 21.11% -26.53% | 28.73% +32.87% | 21.62% -55.05% | 48.10% -19.07% | |
Operating Margin | -153.97% +18.05% | -130.42% -54.14% | -284.40% +42.61% | -199.43% +333.66% | |
Return on Assets | -14.75% +25.40% | -11.76% -37.46% | -18.81% +11.65% | -16.85% +72.42% | |
Return on Equity | -22.50% +3.90% | -21.65% -43.24% | -38.15% +7.69% | -35.42% +63.46% | |
Revenue Growth | -9.73% +344.15% | -2.19% -90.96% | -24.23% -46.78% | -45.53% +510.99% | |
Current Ratio | 3.54 +121.55% | 1.60 +18.74% | 1.35 +2.69% | 1.31 +4.86% | |
Cash Ratio | 3.01 +122.03% | 1.36 +13.17% | 1.20 +32.14% | 0.91 +26.35% | |
Debt-to-Equity Ratio | 0.05 +15.45% | 0.05 +126.50% | 0.02 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.04 +36.63% | 0.03 +175.76% | 0.010 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow